Literature DB >> 23916466

Axis I psychiatric diagnoses in adolescents and young adults with 22q11 deletion syndrome.

O Y Ousley1, E Smearman, S Fernandez-Carriba, K A Rockers, K Coleman, E F Walker, J F Cubells.   

Abstract

BACKGROUND: 22q11.2 deletion syndrome (22q11DS) associates with schizophrenia spectrum disorders (SSDs), autism spectrum disorders (ASDs), and other psychiatric disorders, but co-occurrence of diagnoses are not well described.
METHODS: We evaluated the co-occurrence of SSDs, ASDs and other axis I psychiatric diagnoses in 31 adolescents and adults with 22q11DS, assessing ASDs using either stringent Collaborative Program for Excellence in Autism (ASD-CPEA) criteria, or less stringent DSM-IV criteria alone (ASD-DSM-IV).
RESULTS: Ten (32%) individuals met criteria for an SSD, five (16%) for ASD-CPEA, and five others (16%) for ASD-DSM-IV. Of those with ASD-CPEA, one (20%) met SSD criteria. Of those with ASD-DSM-IV, four (80%) met SSD criteria. Depressive disorders (8 individuals; 26%) and anxiety disorders (7; 23%) sometimes co-occurred with SSDs and ASDs. SSDs, ASDs, and anxiety occurred predominantly among males and depression predominantly among females.
CONCLUSIONS: Individuals with 22q11DS can manifest SSDs in the presence or absence of ASDs and other axis I diagnoses. The results suggest that standard clinical care should include childhood screening for ASDs, and later periodic screening for all axis I diagnoses.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Affective disorders; Anxiety disorders; Autism; Genetics; Schizophrenia and psychosis

Mesh:

Year:  2013        PMID: 23916466      PMCID: PMC5700766          DOI: 10.1016/j.eurpsy.2013.06.002

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  37 in total

1.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.

Authors:  Tandy J Miller; Thomas H McGlashan; Joanna L Rosen; Kristen Cadenhead; Tyrone Cannon; Joseph Ventura; William McFarlane; Diana O Perkins; Godfrey D Pearlson; Scott W Woods
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

2.  Clinically detectable copy number variations in a Canadian catchment population of schizophrenia.

Authors:  Anne S Bassett; Gregory Costain; Wai Lun Alan Fung; Kathryn J Russell; Laura Pierce; Ronak Kapadia; Ronald F Carter; Eva W C Chow; Pamela J Forsythe
Journal:  J Psychiatr Res       Date:  2010-11       Impact factor: 4.791

3.  Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk.

Authors:  T H McGlashan; T J Miller; S W Woods
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

4.  Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives.

Authors:  A E Pulver; G Nestadt; R Goldberg; R J Shprintzen; M Lamacz; P S Wolyniec; B Morrow; M Karayiorgou; S E Antonarakis; D Housman
Journal:  J Nerv Ment Dis       Date:  1994-08       Impact factor: 2.254

5.  The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism.

Authors:  C Lord; S Risi; L Lambrecht; E H Cook; B L Leventhal; P C DiLavore; A Pickles; M Rutter
Journal:  J Autism Dev Disord       Date:  2000-06

6.  Copy number variants: a new molecular frontier in clinical psychiatry.

Authors:  Daniel Moreno-De-Luca; Joseph F Cubells
Journal:  Curr Psychiatry Rep       Date:  2011-04       Impact factor: 5.285

7.  Prodromal symptoms in adolescents with 22q11.2 deletion syndrome and schizotypal personality disorder.

Authors:  D I Shapiro; J F Cubells; O Y Ousley; K Rockers; E F Walker
Journal:  Schizophr Res       Date:  2011-04-19       Impact factor: 4.939

8.  Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?

Authors:  D F Papolos; G L Faedda; S Veit; R Goldberg; B Morrow; R Kucherlapati; R J Shprintzen
Journal:  Am J Psychiatry       Date:  1996-12       Impact factor: 18.112

9.  Rare chromosomal deletions and duplications increase risk of schizophrenia.

Authors: 
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

10.  The schizophrenia phenotype in 22q11 deletion syndrome.

Authors:  Anne S Bassett; Eva W C Chow; Philip AbdelMalik; Mirona Gheorghiu; Janice Husted; Rosanna Weksberg
Journal:  Am J Psychiatry       Date:  2003-09       Impact factor: 18.112

View more
  6 in total

1.  The effect of hypocalcemia in early childhood on autism-related social and communication skills in patients with 22q11 deletion syndrome.

Authors:  Meghan Muldoon; Opal Y Ousley; Lisa J Kobrynski; Sheena Patel; Matthew E Oster; Samuel Fernandez-Carriba; Joseph F Cubells; Karlene Coleman; Bradley D Pearce
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-30       Impact factor: 5.270

2.  Identification of the antigenic epitopes of maternal autoantibodies in autism spectrum disorders.

Authors:  Elizabeth Edmiston; Karen L Jones; Tam Vu; Paul Ashwood; Judy Van de Water
Journal:  Brain Behav Immun       Date:  2017-12-28       Impact factor: 7.217

3.  A rare association of schizophrenia and Mayer-Rokitansky-Küster-Hauser syndrome.

Authors:  Roshan Bhad; Rakesh Chadda; Nand Kumar; Prashant Goyal
Journal:  Indian J Psychiatry       Date:  2015 Jul-Sep       Impact factor: 1.759

4.  Examining the Overlap between Autism Spectrum Disorder and 22q11.2 Deletion Syndrome.

Authors:  Opal Ousley; A Nichole Evans; Samuel Fernandez-Carriba; Erica L Smearman; Kimberly Rockers; Michael J Morrier; David W Evans; Karlene Coleman; Joseph Cubells
Journal:  Int J Mol Sci       Date:  2017-05-18       Impact factor: 5.923

5.  The social brain network in 22q11.2 deletion syndrome: a diffusion tensor imaging study.

Authors:  Amy K Olszewski; Zora Kikinis; Christie S Gonzalez; Ioana L Coman; Nikolaos Makris; Xue Gong; Yogesh Rathi; Anni Zhu; Kevin M Antshel; Wanda Fremont; Marek R Kubicki; Sylvain Bouix; Martha E Shenton; Wendy R Kates
Journal:  Behav Brain Funct       Date:  2017-02-16       Impact factor: 3.759

6.  Opposing white matter microstructure abnormalities in 22q11.2 deletion and duplication carriers.

Authors:  Johanna Seitz-Holland; Monica Lyons; Leila Kushan; Amy Lin; Julio E Villalon-Reina; Kang Ik Kevin Cho; Fan Zhang; Tashrif Billah; Sylvain Bouix; Marek Kubicki; Carrie E Bearden; Ofer Pasternak
Journal:  Transl Psychiatry       Date:  2021-11-10       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.